Haisco Pharmaceutical Group has filed a patent for a pharmaceutical salt of a compound degrading BTK, available in various forms like maleate, fumarate, hydrobromide, hydrochloride, and more. The patent aims to protect the unique formulation and application of the compound. GlobalData’s report on Haisco Pharmaceutical Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

According to GlobalData’s company profile on Haisco Pharmaceutical Group, Peptide nano-particle conjugates was a key innovation area identified from patents. Haisco Pharmaceutical Group's grant share as of January 2024 was 29%. Grant share is based on the ratio of number of grants to total number of patents.

Pharmaceutical salt of compound for degrading btk

Source: United States Patent and Trademark Office (USPTO). Credit: Haisco Pharmaceutical Group Co Ltd

The patent application US20240018147A1 discloses a pharmaceutical salt of a compound represented by formula (I), with specific reference to compounds shown in formulas (Ia) or (Ib). The pharmaceutical salt can be selected from maleate, fumarate, L-tartrate, citrate, L-malate, salicylate, or oxalate. Additionally, the patent describes crystal forms I and III of the compound represented by formula (II) and formula (Ia) respectively, detailing their X-ray powder diffraction patterns and characteristic diffraction peaks.

Furthermore, the patent application includes claims related to the pharmaceutical composition containing the pharmaceutical salt of the compound and a pharmaceutically acceptable excipient. It also outlines a method for treating and/or preventing tumors or cancer by administering the pharmaceutical salt of the compound to a patient. The detailed description provided in the claims offers valuable insights into the specific formulations and methods disclosed in the patent application, highlighting the potential therapeutic applications of the compounds described.

To know more about GlobalData’s detailed insights on Haisco Pharmaceutical Group, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies